Project Grant 2234394
Award Date
9/15/23
Completion Date
8/31/26
Dollars Obligated
$550K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14627, USA
Similar Awards
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is focused on developing an affordable, portable virus detection platform. The $331,189 project, awarded on April 1, 2025 and running through March 31, 2028, integrates protein engineering and electrochemical biosensor technologies to create a virus detection system that can operate in resource-limited environments. The innovation lies in using stable...
This National Science Foundation (NSF) CAREER grant, awarded under the Engineering program (CFDA 47.041), provides $242,687 to the University of Massachusetts (UMass) to develop an ultrasensitive nanopore biosensor technology for point-of-care detection of infectious disease biomarkers. The project aims to create a next-generation nanopore sensor with unprecedented sensitivity, robustness, and reproducibility to enable rapid, accurate, and multiplexed quantification of circulating proteomics...
Under a $997,781 cooperative agreement awarded by the National Science Foundation (NSF) through its Technology, Innovation, and Partnerships (CFDA 47.084) program, Nanopath Inc. - a woman-owned small business - is developing an integrated point-of-care system for rapid pathogen identification and characterization. The system utilizes proprietary nanosensor technology to detect target nucleic acid sequences directly from patient samples, eliminating the need for bacterial culture or nucleic...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Anvil Diagnostics Inc. in Cambridge, MA provides $298,646 to develop a rapid diagnostic test for detecting sepsis-causing pathogens in plasma samples. The proposed technology aims to comprehensively identify and quantify a wide range of pathogens from small blood volumes within 4 hours, addressing critical limitations of current sepsis diagnostics. The innovations focus on...
This $1,016,000.00 Project Grant award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program will fund the development and application of a low-cost, portable biosensing platform for detecting and monitoring waterborne pathogens in aquaculture and coastal environments. The University of Massachusetts Lowell, as the prime awardee, will lead the effort to adapt its patented biosensing technology to enable real-time pathogen detection and...
This $305,000 Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a point-of-care diagnostic platform by Resonantia Diagnostics, Inc. that can rapidly identify pathogens and determine their antimicrobial susceptibility within 60 minutes. The key technical objectives of this 1-year project are to: (1) demonstrate accurate antimicrobial susceptibility testing at low pathogen loads, (2)...
This National Science Foundation Technology, Innovation, and Partnerships Project Grant totaling $265,999 will support Rutgers, The State University of New Jersey, Camden in developing a rapid and reliable point-of-care screening for infectious diseases such as COVID-19. Specifically, the university will demonstrate a mass screening method to rapidly detect viruses to identify early infected individuals for quarantine. This work will enable rapid and reliable point-of-care detection with...
This $402,222 National Science Foundation Project Grant, funded through the Engineering program (CFDA 47.041), supports the development of a new class of simple, inexpensive, portable, and rapid molecular diagnostic platforms. The awardee, University of Cincinnati, will engineer an instrument that can reliably and quickly detect infectious diseases in human samples using a combination of biochemistry, magnetism, fluid physics, and machine learning insights. Specifically, the university will...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 supports the development of an automated, AI-supported platform for rapid detection of food pathogens. The key products/services to be delivered include: Building an automated sample preparation module to enhance pathogen enrichment across food groups. Developing an automated experimental design workflow to accelerate the optimization of enrichment time. Using...